BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27613337)

  • 1. The role of the p53 tumor suppressor in metabolism and diabetes.
    Kung CP; Murphy ME
    J Endocrinol; 2016 Nov; 231(2):R61-R75. PubMed ID: 27613337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution.
    Condorelli RA; Calogero AE; Di Mauro M; La Vignera S
    Gynecol Endocrinol; 2017 Sep; 33(9):665-667. PubMed ID: 28644709
    [No Abstract]   [Full Text] [Related]  

  • 3. Autophagy and pancreatic β-cells.
    Mazza S; Maffucci T
    Vitam Horm; 2014; 95():145-64. PubMed ID: 24559917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes.
    Yoneda S; Uno S; Iwahashi H; Fujita Y; Yoshikawa A; Kozawa J; Okita K; Takiuchi D; Eguchi H; Nagano H; Imagawa A; Shimomura I
    J Clin Endocrinol Metab; 2013 May; 98(5):2053-61. PubMed ID: 23539729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperstimulated β-cell: prelude to diabetes?
    Boitard C; Accili D; Ahrén B; Cerasi E; Seino S; Thorens B
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():iv-viii. PubMed ID: 22928578
    [No Abstract]   [Full Text] [Related]  

  • 6. MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes.
    Latouche C; Natoli A; Reddy-Luthmoodoo M; Heywood SE; Armitage JA; Kingwell BA
    PLoS One; 2016; 11(5):e0155108. PubMed ID: 27163678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tumor suppressor p53 in metabolism and energy regulation, and its implication in cancer and lifestyle-related diseases.
    Hashimoto N; Nagano H; Tanaka T
    Endocr J; 2019 Jun; 66(6):485-496. PubMed ID: 31105124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology?
    Patti ME
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):383-90. PubMed ID: 15192439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGC-1α, glucose metabolism and type 2 diabetes mellitus.
    Wu H; Deng X; Shi Y; Su Y; Wei J; Duan H
    J Endocrinol; 2016 Jun; 229(3):R99-R115. PubMed ID: 27094040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Roles of p53 Family Members in Glucose Metabolism.
    Itahana Y; Itahana K
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective ablation of P53 in pancreatic beta cells fails to ameliorate glucose metabolism in genetic, dietary and pharmacological models of diabetes mellitus.
    Uhlemeyer C; Müller N; Rieck M; Kuboth J; Schlegel C; Grieß K; Dorweiler TF; Heiduschka S; Eckel J; Roden M; Lammert E; Stoffel M; Belgardt BF
    Mol Metab; 2023 Jan; 67():101650. PubMed ID: 36470401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and the functional β cell mass: For better or worse.
    Guay C; Regazzi R
    Diabetes Metab; 2015 Nov; 41(5):369-77. PubMed ID: 25910875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic regulation of insulin secretion.
    Keane K; Newsholme P
    Vitam Horm; 2014; 95():1-33. PubMed ID: 24559912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes risk alleles near BCAR1 and in ANK1 associate with decreased β-cell function whereas risk alleles near ANKRD55 and GRB14 associate with decreased insulin sensitivity in the Danish Inter99 cohort.
    Harder MN; Ribel-Madsen R; Justesen JM; Sparsø T; Andersson EA; Grarup N; Jørgensen T; Linneberg A; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E801-6. PubMed ID: 23457408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic roles of PGC-1α and its implications for type 2 diabetes.
    Besseiche A; Riveline JP; Gautier JF; Bréant B; Blondeau B
    Diabetes Metab; 2015 Nov; 41(5):347-57. PubMed ID: 25753246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a cross-sectional study.
    Bonfigli AR; Sirolla C; Testa R; Cucchi M; Spazzafumo L; Salvioli S; Ceriello A; Olivieri F; Festa R; Procopio AD; Brandoni G; Boemi M; Marra M; Franceschi C
    Acta Diabetol; 2013 Jun; 50(3):429-36. PubMed ID: 23269546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Fas activity rescues early onset of diabetes in c-Kit(Wv/+) mice.
    Feng ZC; Riopel M; Li J; Donnelly L; Wang R
    Am J Physiol Endocrinol Metab; 2013 Mar; 304(6):E557-65. PubMed ID: 23269409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clock genes, pancreatic function, and diabetes.
    Vieira E; Burris TP; Quesada I
    Trends Mol Med; 2014 Dec; 20(12):685-93. PubMed ID: 25457619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.